Литература (всего 203 источника) 

1. Xiao AY, Tan ML, Wu LM, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol 2016;1:45–55.

2. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102–11.

3. Garg PK, Madan K, Pande GK, et al. Association of extent and infection of pancreatic necrosis with organ failure and death in acute necrotizing pancreatitis. Clin Gastroenterol Hepatol 2005;3:159–66.

4. Johnson CD, Abu-Hilal M. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004;53:1340–4. 

 5. Mofidi R, Duff MD, Wigmore SJ, et al. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. The British journal of surgery 2006;93:738–44.

6. Shen HN, Lu CL. Incidence, resource use, and outcome of acute pancreatitis with/without intensive care: a nationwide population-based study in Taiwan. Pancreas 2011;40:10–5.

7. Hamada S, Masamune A, Kikuta K, et al. Nationwide epidemiological survey of acute pancreatitis in Japan. Pancreas 2014;43:1244–8.

8. Kamal A, Sinha A, Hutfless SM, et al. Hospital admission volume does not impact the in-hospital mortality of acute pancreatitis. HPB (Oxford) 2017;19:21–28.

9. Padhan RK, Jain S, Agarwal S, et al. Primary and Secondary Organ Failures Cause Mortality Differentially in Acute Pancreatitis and Should be Distinguished. Pancreas 2018;47:302–307.

10. Schepers NJ, Bakker OJ, Besselink MG, et al. Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis. Gut 2018.

11. Lowenfels AB, Maisonneuve P, Sullivan T. The changing character of acute pancreatitis: epidemiology, etiology, and prognosis. Curr Gastroenterol Rep 2009;11:97–103.

12. Carvalho JR, Fernandes SR, Santos P, et al. Acute pancreatitis in the elderly: a cause for increased concern? Eur J Gastroenterol Hepatol 2018;30:337–341.

13. Sternby H, Bolado F, Canaval-Zuleta HJ, et al. Determinants of Severity in Acute Pancreatitis: A Nation-wide Multicenter Prospective Cohort Study. Ann Surg 2018.

14. Krishna SG, Hinton A, Oza V, et al. Morbid Obesity Is Associated With Adverse Clinical Outcomes in Acute Pancreatitis: A Propensity-Matched Study. Am J Gastroenterol 2015;110:1608–19.

15. Yoon SB, Choi MH, Lee IS, et al. Impact of body fat and muscle distribution on severity of acute pancreatitis. Pancreatology 2017;17:188–193.

16. Navina S, Acharya C, DeLany JP, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med 2011;3:107ra110. 

17. Noel P, Patel K, Durgampudi C, et al. Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections. Gut 2016;65:100–11. 

18. Nawaz H, Koutroumpakis E, Easler J, et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am J Gastroenterol 2015;110:1497–503.

19. Isenmann R, Rau B, Beger HG. Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas 2001;22:274–8.

20. Tenner S, Sica G, Hughes M, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997;113:899–903.

21. Lankisch PG, Pflichthofer D, Lehnick D. No strict correlation between necrosis and organ failure in acute pancreatitis. Pancreas 2000;20:319–22.

22. Isenmann R, Rau B, Beger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 1999;86:1020–4.

23. Singh P, Garg PK. Pathophysiological mechanisms in acute pancreatitis: Current understanding. Indian J Gastroenterol 2016;35:153–66.

24. Mole DJ, McClymont KL, Lau S, et al. Discrepancy between the extent of pancreatic necrosis and multiple organ failure score in severe acute pancreatitis. World J Surg 2009;33:2427–32.

25. Sah RP, Garg P, Saluja AK. Pathogenic mechanisms of acute pancreatitis. Curr Opin Gastroenterol 2012;28:507–15. 

26. de-Madaria E, Martinez J, Sempere L, et al. Cytokine genotypes in acute pancreatitis: association with etiology, severity, and cytokine levels in blood. Pancreas 2008;37:295–301.

27. Bishehsari F, Sharma A, Stello K, et al. TNF-alpha gene (TNFA) variants increase risk for multi-organ dysfunction syndrome (MODS) in acute pancreatitis. Pancreatology 2012;12:113–8. 

28. Yang Z, Qi X, Wu Q, et al. Lack of association between TNF-alpha gene promoter polymorphisms and pancreatitis: a meta-analysis. Gene 2012;503:229–34.

29. Chen WC, Nie JS. Genetic polymorphism of MCP-1-2518, IL-8-251 and susceptibility to acute pancreatitis: a pilot study in population of Suzhou, China. World J Gastroenterol 2008;14:5744–8. 

30. Papachristou GI, Sass DA, Avula H, et al. Is the monocyte chemotactic protein-1 −2518 G allele a risk factor for severe acute pancreatitis? Clin Gastroenterol Hepatol 2005;3:475–81.

31. Sharma M, Banerjee D, Garg PK. Characterization of newer subgroups of fulminant and subfulminant pancreatitis associated with a high early mortality. Am J Gastroenterol 2007;102:2688–95.

32. Wig JD, Bharathy KG, Kochhar R, et al. Correlates of organ failure in severe acute pancreatitis. JOP 2009;10:271–5.

33. Mole DJ, Olabi B, Robinson V, et al. Incidence of individual organ dysfunction in fatal acute pancreatitis: analysis of 1024 death records. HPB (Oxford) 2009;11:166–70. 

34. Chandra S, Murali A, Bansal R, et al. The Bedside Index for Severity in Acute Pancreatitis: a systematic review of prospective studies to determine predictive performance. J Community Hosp Intern Med Perspect 2017;7:208–213. 

35. Wu BU, Johannes RS, Sun X, et al. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut 2008;57:1698–703.

36. Parniczky A, Kui B, Szentesi A, et al. Prospective, Multicentre, Nationwide Clinical Data from 600 Cases of Acute Pancreatitis. PLoS One 2016;11:e0165309. 

37. Sathyanarayan G, Garg PK, Prasad H, et al. Elevated level of interleukin-6 predicts organ failure and severe disease in patients with acute pancreatitis. J Gastroenterol Hepatol 2007;22:550–4.

38. Mofidi R, Duff MD, Wigmore SJ, et al. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg 2006;93:738–44.

39. Singh VK, Wu BU, Bollen TL, et al. Early systemic inflammatory response syndrome is associated with severe acute pancreatitis. Clin Gastroenterol Hepatol 2009;7:1247–51.

40. Jain S, Midha S, Mahapatra SJ, et al. Interleukin-6 significantly improves predictive value of systemic inflammatory response syndrome for predicting severe acute pancreatitis. Pancreatology 2018.

41. Garret C, Peron M, Reignier J, et al. Risk factors and outcomes of infected pancreatic necrosis: Retrospective cohort of 148 patients admitted to the ICU for acute pancreatitis. United European Gastroenterol J 2018;6:910–918. 

42. Thandassery RB, Yadav TD, Dutta U, et al. Hypotension in the first week of acute pancreatitis and APACHE II score predict development of infected pancreatic necrosis. Dig Dis Sci 2015;60:537–42. [PubMed] [Google Scholar]

43. Petrov MS, Shanbhag S, Chakraborty M, et al. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology 2010;139:813–20.

44. Deng LH, Xue P, Xia Q, et al. Effect of admission hypertriglyceridemia on the episodes of severe acute pancreatitis. World J Gastroenterol 2008;14:4558–61. 

45. Lloret Linares C, Pelletier AL, Czernichow S, et al. Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas 2008;37:13–2.

46. Wang Y, Sternfeld L, Yang F, et al. Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells. Gut 2009;58:422–30.

47. Noel P, Patel K, Durgampudi C, et al. Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections. Gut 2014. [PMC free article] 

48. Patel K, Trivedi RN, Durgampudi C, et al. Lipolysis of visceral adipocyte triglyceride by pancreatic lipases converts mild acute pancreatitis to severe pancreatitis independent of necrosis and inflammation. The American journal of pathology 2015;185:808–19. 

 49. Durgampudi C, Noel P, Patel K, et al. Acute Lipotoxicity Regulates Severity of Biliary Acute Pancreatitis without Affecting Its Initiation. The American journal of pathology 2014;184:1773–84. 

50. Song AM, Bhagat L, Singh VP, et al. Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 2002;283:G1166–74.

51. Hofbauer B, Saluja AK, Bhatia M, et al. Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. Gastroenterology 1998;115:1238–47.

52. Bhatia M, Saluja AK, Hofbauer B, et al. The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury. Int J Pancreatol 1998;24:77–83.

53. Navina S, Acharya C, DeLany JP, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Science translational medicine 2011;3:107ra110. [PMC free article] 

54. Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011;6:147–63. 

55. Wu BU, Johannes RS, Sun X, et al. Early changes in blood urea nitrogen predict mortality in acute pancreatitis. Gastroenterology 2009;137:129–35.

56. Geokas MC, Rinderknecht H, Brodrick JW, et al. Studies on the ascites fluid of acute pancreatitis in man. Am J Dig Dis 1978;23:182–8.

57. Buchler M, Malfertheiner P, Uhl W, et al. [Gabexate mesilate in the therapy of acute pancreatitis. Multicenter study of tolerance of a high intravenous dose (4 g/day)]. Medizinische Klinik 1988;83:320–4, 352.

58. Berling R, Borgstrom A, Ohlsson K. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors. Int J Pancreatol 1998;24:9–17.

59. Renner IG, Rinderknecht H, Douglas AP. Profiles of pure pancreatic secretions in patients with acute pancreatitis: the possible role of proteolytic enzymes in pathogenesis. Gastroenterology 1978;75:1090–8.

60. Chiari H Ueber Selbstverdauung des menschlichen Pankreas. Zeitschrift für Heilkunde 1896;17:69–96. 

61. Jobling JW, Petersen W, Eggstein AA. Serum Ferments and Antiferment during Trypsin Shock : Studies on Ferment Action. Xxii. J Exp Med 1915;22:141–53. 

62. Tagnon HJ. The Nature of the Mechanism of the Shock Produced by the Injection of Trypsin and Thrombin. J Clin Invest 1945;24:1–10. 

63. Radenkovic D, Bajec D, Ivancevic N, et al. D-dimer in acute pancreatitis: a new approach for an early assessment of organ failure. Pancreas 2009;38:655–60.

64. Easler J, Muddana V, Furlan A, et al. Portosplenomesenteric venous thrombosis in patients with acute pancreatitis is associated with pancreatic necrosis and usually has a benign course. Clin Gastroenterol Hepatol 2014;12:854–62.

65. Hartwig W, Werner J, Jimenez RE, et al. Trypsin and activation of circulating trypsinogen contribute to pancreatitis-associated lung injury. Am J Physiol 1999;277:G1008–16.

66. Singh VP, Bhagat L, Navina S, et al. Protease-activated receptor-2 protects against pancreatitis by stimulating exocrine secretion. Gut 2007;56:958–64. 

 67. Namkung W, Han W, Luo X, et al. Protease-activated receptor 2 exerts local protection and mediates some systemic complications in acute pancreatitis. Gastroenterology 2004;126:1844–59.

68. Andriulli A, Caruso N, Quitadamo M, et al. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. JOP : Journal of the pancreas 2003;4:41–8.

69. Andriulli A, Leandro G, Clemente R, et al. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Alimentary pharmacology & therapeutics 1998;12:237–45.

70. Asang E [Changes in the therapy of inflammatory diseases of the pancreas. A report on 1 year of therapy and prophylaxis with the kallikrein- and trypsin inactivator trasylol (Bayer)]. Langenbecks Arch Klin Chir Ver Dtsch Z Chir 1960;293:645–70.

71. Buchler M, Malfertheiner P, Uhl W, et al. Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology 1993;104:1165–70.

72. Chen HM, Chen JC, Hwang TL, et al. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Hepato-gastroenterology 2000;47:1147–50.

73. Park KT, Kang DH, Choi CW, et al. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients? Pancreas 2011;40:1215–9.

74. Seta T, Noguchi Y, Shimada T, et al. Treatment of acute pancreatitis with protease inhibitors: a meta-analysis. Eur J Gastroenterol Hepatol 2004;16:1287–93.

75. Trapnell JE, Rigby CC, Talbot CH, et al. Proceedings: Aprotinin in the treatment of acute pancreatitis. Gut 1973;14:828.

76. Trapnell JE, Rigby CC, Talbot CH, et al. A controlled trial of Trasylol in the treatment of acute pancreatitis. The British journal of surgery 1974;61:177–82.

77. Trapnell JE, Talbot CH, Capper WM. Trasylol in acute pancreatitis. The American journal of digestive diseases 1967;12:409–12.

78. Rebours V, Boutron-Ruault MC, Jooste V, et al. Mortality rate and risk factors in patients with hereditary pancreatitis: uni- and multidimensional analyses. The American journal of gastroenterology 2009;104:2312–7.

79. Nakae Y, Hayakawa T, Kondo T, et al. Serum alpha 2-macroglobulin-trypsin complex and early recognition of severe acute pancreatitis after endoscopic retrograde pancreatography. J Gastroenterol Hepatol 1994;9:272–6.

80. McMahon MJ, Bowen M, Mayer AD, et al. Relation of alpha 2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. Am J Surg 1984;147:164–70.

81. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–55.

82. Keck T, Balcom JHt, Fernandez-del Castillo C, et al. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 2002;122:188–201.

83. Inoue S, Nakao A, Kishimoto W, et al. Anti-neutrophil antibody attenuates the severity of acute lung injury in rats with experimental acute pancreatitis. Arch Surg 1995;130:93–8.

84. Telek G, Ducroc R, Scoazec JY, et al. Differential upregulation of cellular adhesion molecules at the sites of oxidative stress in experimental acute pancreatitis. J Surg Res 2001;96:56–67.

85. Powell JJ, Siriwardena AK, Fearon KC, et al. Endothelial-derived selectins in the development of organ dysfunction in acute pancreatitis. Crit Care Med 2001;29:567–72.

86. Wetterholm E, Linders J, Merza M, et al. Platelet-derived CXCL4 regulates neutrophil infiltration and tissue damage in severe acute pancreatitis. Transl Res 2016;176:105–18.

87. Lira SA. Genetic approaches to study chemokine function. Journal of leukocyte biology 1996;59:45–52.

88. Mehrad B, Wiekowski M, Morrison BE, et al. Transient lung-specific expression of the chemokine KC improves outcome in invasive aspergillosis. American journal of respiratory and critical care medicine 2002;166:1263–8.

89. Tsai WC, Strieter RM, Wilkowski JM, et al. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. Journal of immunology 1998;161:2435–40.